We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Marinomed

News List

Luoxin Pharmaceutical signs licensing agreement with Austria-based Marinomed Biotech AG for Budesolv® Budesonide Nasal Spray prnasia
October 22, 2021
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. (''Shandong Luoxin''), a subsidiary of Luoxin Pharmaceutical Group Stock Co., Ltd. ("Luoxin Pharmaceutical" or "the company") ...
Marinomed receives FFG funding to research SARS-CoV-2 therapy based on carragelose expresspharma
April 29, 2020
Available clinical data show that Carragelose binds previously known coronaviruses and other viruses that trigger respiratory infections.
Marinomed effectively tests new combination drug against VRTI biospectrumasia
July 19, 2018
A comprehensive series of tests conducted by Marinomed suggest that these can be effectively treated using a combination of Carragelose for its efficacy against cold viruses, and Xylometazoline a well-known drug that targets inflamed nasal mucous membrane